Unlike many peptides, BPC-157 is remarkably stable in human gastric juice for extended periods (over 24 hours), a property that is unusual for a peptide of its size and that makes it viable for both injectable and oral research protocols
Studies indicate that BPC-157 promotes fibroblast proliferation, new blood vessel formation, and collagen synthesis processes central to the repair of muscles, tendons, ligaments, and mucosal tissues (Staresinic et al., 2003)
These side effects vary widely by individual and often diminish over time
71 However, safely targeting specific tissue and avoiding side effects using miRNA therapeutics is still a challenge
Interesting paper by Viral N Shah, Tadej Battelino, Moshe Phillip and Rich Bergenstal
There is no need to aspirate for a subQ injection